Journals / Ortadoğu Tıp Dergisi / 2015 / Cilt: 7 - Sayı: 1

Delta Hepatitis Frequency in Chronic Hepatitis B Patients: Single Center Retrospective Study

Kronik Hepatit B Hastalarında Delta Hepatit Sıklığı: Tek Merkez Retrospektif Çalışma

Pages
12–15
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This results supported the literatüre determined from devoloping countriesof the world.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: To determine the incidence of HDV in chronic HBV population at a tertiary reference hospital.
📊
Key Findings & Data:Material and Methods: All of the HBV positive patients were included in to the study between May 2012 and May2014.
💡
Conclusion & Impact:This results supported the literatüre determined from devoloping countriesof the world.
🔬Design:Review & Systematic Survey
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: To determine the incidence of HDV in chronic HBV population at a tertiary reference hospital. Material and Methods: All of the HBV positive patients were included in to the study between May 2012 and May2014. Results: Mean age of 1035 patients was 48 (17-90) years old and 58,1 % of them were male. Anti HDV positivitywas found in 31 patients (3 %). Only 11,6 % of our patients were HBe Ag (+).Conclusion: The rate of HDV positivity among HBV patients 3 % in our hospital was similar with the recent in- vestigation published in western part of Turkey. The mean HDV prevalence was reported as 1,96,3 % in previousstudies from western to eastern Turkey. This results supported the literatüre determined from devoloping countriesof the world.

Özet

Amaç: Bu çalışmada üçüncü basamak bir referans hastanesi olan Ankara Numune Eğitim ve Araştırma HastanesiGastroenteroloji Kliniğine başvuran kronik HBV hastalarında HDV görülme sıklığının tespit edilmesi amaçlanmıştır. Yöntem ve Gereçler: Çalışmamıza Mayıs 2012 ile Mayıs 2014 arasında takip edilen tüm HBV pozitif hastalar dahiledilmiştir.Bulgular: Çalışmaya alınan 1035 hastanın ortalama yaşı 48 (17-90) olup hastaların % 58,1i erkekti. otuz bir hastada(% 3) anti HDV pozitifti. Hastaların sadece % 11,6sı HBe Ag (+)di.Sonuç: Türkiyenin batısında daha önce yapılan çalışmalara benzer şekilde hastanemizdeki HBV hastalarında HDVpozitiflik oranı % 3 idi. Daha önceki çalışmalarda Türkiyenin doğusuyla batısı arasında HDV pozitiflik oranı % 1,9ile % 6,3 arasında değişmektedir. Bu sonuçlar gelişmekte olan ülkelerde yapılan daha önceki çalışmalar ile benzerdir.

🔖

Cite This Article

ALTIPARMAK, E., ÜNER, E., YOZGAT, A., ÖZASLAN, E., ÇETİN, F., ERTEN, A. T., DEMİRCİ, S., ALİYAZICIOĞLU, M., ÇAĞLAYAN, Ö., KÖSEOĞLU, H. T. (2022). Delta Hepatitis Frequency in Chronic Hepatitis B Patients: Single Center Retrospective Study. Ortadoğu Tıp Dergisi, Cilt: 7 - Sayı: 1, 12–15. https://ajindex.com/articles/585836

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Lin, J.H., et al., Characterization of hepatitis delta antigen: specific binding to hepatitis delta virus RNA. J Virol, 1990. 64(9): p. 4051-8
  2. Yurdaydin, C., et al., Natural history and treatment of chronic delta hepatitis. J Viral Hepat, 2010. 17(11): p. 749-56
  3. Taylor, J., Negro, F, Rizzetto, M, Hepatitis delta virus: From structure to disease expression. 1992: Rev Med Virol
  4. Shakil, A.O., et al., Geographic distribution and genetic variability of hepatitis delta virus genotype I. Virology, 1997. 234(1): p. 160-7
  5. Wu, J.C., et al., Genotyping of hepatitis D virus by restriction- fragment length polymorphism and relation to outcome of hepatitis D. Lancet, 1995. 346(8980): p. 939-41
  6. Hadler, S.C., et al., Epidemiology and long-term consequences of hepatitis delta virus infection in the Yucpa Indians of Venezuela. Am J Epidemiol, 1992. 136(12): p. 1507-16
  7. Popper, H., et al., Histologic studies of severe delta agent infection in Venezuelan Indians. Hepatology, 1983. 3(6): p. 906-12
  8. Le Gal, F., et al., Eighth major clade for hepatitis delta virus. Emerg Infect Dis, 2006. 12(9): p. 1447-50
  9. Taylor, J.M., Hepatitis delta virus. Virology, 2006. 344(1): p. 71-6
  10. Davaalkham, D., et al., Hepatitis delta virus infection in mongolia: analyses of geographic distribution, risk factors, and disease severity. Am J Trop Med Hyg, 2006. 75(2): p. 365-9
  11. Aragona, M., et al., Serological response to the hepatitis delta virus in hepatitis D. Lancet, 1987. 1(8531): p. 478-80
  12. Williams, V., et al., Hepatitis delta virus proteins repress hepatitis B virus enhancers and activate the alpha/beta interferon-inducible MxA gene. J Gen Virol, 2009. 90(Pt 11): p. 2759-67
  13. Abbas, Z. and R. Afzal, Life cycle and pathogenesis of hepatitis D virus: A review. World J Hepatol, 2013. 5(12): p. 666-75
  14. Wedemeyer, H., et al., Peginterferon plus adefovir versus either drug alone for hepatitis delta. N Engl J Med, 2011. 364(4): p. 322-31
  15. Rizzetto, M., A. Ponzetto, and I. Forzani, Epidemiology of hepatitis delta virus: overview. Prog Clin Biol Res, 1991. 364: p. 1-20
  16. MCC, L., ed. Hepatitis Delta Virus. Encyclopedia of Virology, ed. G.A. Webster RG 1994, Academic Press LTD.: London. 574-580
  17. Degertekin, H., et al., Seropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey: a meta- analysis. Liver Int, 2008. 28(4): p. 494-8
  18. Degertekin, H. and G. Gunes, Horizontal transmission of hepatitis B